Literature DB >> 27474742

A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis.

Robert J Andrew1, Katherine A B Kellett2, Gopal Thinakaran3, Nigel M Hooper4.   

Abstract

Proteolysis of the amyloid precursor protein (APP) liberates various fragments including the proposed initiator of Alzheimer disease-associated dysfunctions, amyloid-β. However, recent evidence suggests that the accepted view of APP proteolysis by the canonical α-, β-, and γ-secretases is simplistic, with the discovery of a number of novel APP secretases (including δ- and η-secretases, alternative β-secretases) and additional metabolites, some of which may also cause synaptic dysfunction. Furthermore, various proteins have been identified that interact with APP and modulate its cleavage by the secretases. Here, we give an overview of the increasingly complex picture of APP proteolysis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ADAM; ADAM10; Alzheimer disease; amyloid; amyloid precursor protein (APP); amyloid-beta (AB); beta-secretase 1 (BACE1); cathepsin B (CTSB); presenilin; protease; proteolysis; secretase

Mesh:

Substances:

Year:  2016        PMID: 27474742      PMCID: PMC5016663          DOI: 10.1074/jbc.R116.746032

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

1.  Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.

Authors:  Emanuela Pasciuto; Tariq Ahmed; Tina Wahle; Fabrizio Gardoni; Laura D'Andrea; Laura Pacini; Sébastien Jacquemont; Flora Tassone; Detlef Balschun; Carlos G Dotti; Zsuzsanna Callaerts-Vegh; Rudi D'Hooge; Ulrike C Müller; Monica Di Luca; Bart De Strooper; Claudia Bagni
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

2.  Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.

Authors:  K Furukawa; B L Sopher; R E Rydel; J G Begley; D G Pham; G M Martin; M Fox; M P Mattson
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

3.  Adaptor protein sorting nexin 17 regulates amyloid precursor protein trafficking and processing in the early endosomes.

Authors:  Jiyeon Lee; Claudio Retamal; Loreto Cuitiño; Amy Caruano-Yzermans; Jung-Eun Shin; Peter van Kerkhof; Maria-Paz Marzolo; Guojun Bu
Journal:  J Biol Chem       Date:  2008-02-13       Impact factor: 5.157

4.  Pharmacological chaperones stabilize retromer to limit APP processing.

Authors:  Vincent J Mecozzi; Diego E Berman; Sabrina Simoes; Chris Vetanovetz; Mehraj R Awal; Vivek M Patel; Remy T Schneider; Gregory A Petsko; Dagmar Ringe; Scott A Small
Journal:  Nat Chem Biol       Date:  2014-04-20       Impact factor: 15.040

5.  The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production.

Authors:  Judy A Cam; Celina V Zerbinatti; Jane M Knisely; Silva Hecimovic; Yonghe Li; Guojun Bu
Journal:  J Biol Chem       Date:  2004-05-04       Impact factor: 5.157

6.  BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2.

Authors:  Shuji Matsuda; Yukiko Matsuda; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

Review 7.  The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes.

Authors:  Hoang S Nhan; Karen Chiang; Edward H Koo
Journal:  Acta Neuropathol       Date:  2014-10-07       Impact factor: 17.088

8.  Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.

Authors:  Alessio Colombo; Huanhuan Wang; Peer-Hendrik Kuhn; Richard Page; Elisabeth Kremmer; Peter J Dempsey; Howard C Crawford; Stefan F Lichtenthaler
Journal:  Neurobiol Dis       Date:  2012-08-24       Impact factor: 5.996

9.  Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

Authors:  Justin M Nussbaum; Stephan Schilling; Holger Cynis; Antonia Silva; Eric Swanson; Tanaporn Wangsanut; Kaycie Tayler; Brian Wiltgen; Asa Hatami; Raik Rönicke; Klaus Reymann; Birgit Hutter-Paier; Anca Alexandru; Wolfgang Jagla; Sigrid Graubner; Charles G Glabe; Hans-Ulrich Demuth; George S Bloom
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

10.  BACE1 inhibitor drugs in clinical trials for Alzheimer's disease.

Authors:  Robert Vassar
Journal:  Alzheimers Res Ther       Date:  2014-12-24       Impact factor: 6.982

View more
  64 in total

1.  APP-Mediated Signaling Prevents Memory Decline in Alzheimer's Disease Mouse Model.

Authors:  Carole Deyts; Mary Clutter; Nicholas Pierce; Paramita Chakrabarty; Thomas B Ladd; Anna Goddi; Awilda M Rosario; Pedro Cruz; Kulandaivelu Vetrivel; Steven L Wagner; Gopal Thinakaran; Todd E Golde; Angèle T Parent
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

2.  PSEN2 (presenilin 2) mutants linked to familial Alzheimer disease impair autophagy by altering Ca2+ homeostasis.

Authors:  Chiara Fedeli; Riccardo Filadi; Alice Rossi; Cristina Mammucari; Paola Pizzo
Journal:  Autophagy       Date:  2019-03-27       Impact factor: 16.016

3.  Characterization of Cerebrospinal Fluid BACE1 Species.

Authors:  Inmaculada Lopez-Font; Claudia P Boix; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2019-07-09       Impact factor: 5.590

4.  CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts.

Authors:  Keiichi Inoue; Luis M A Oliveira; Asa Abeliovich
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

Review 5.  Motifs and interface amino acid-mediated regulation of amyloid biogenesis in microbes to humans: potential targets for intervention.

Authors:  Ayesha Z Beg; Asad U Khan
Journal:  Biophys Rev       Date:  2020-09-15

Review 6.  APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

Authors:  Alex E Roher; Tyler A Kokjohn; Steven G Clarke; Michael R Sierks; Chera L Maarouf; Geidy E Serrano; Marwan S Sabbagh; Thomas G Beach
Journal:  Neurochem Int       Date:  2017-08-12       Impact factor: 3.921

Review 7.  Not just amyloid: physiological functions of the amyloid precursor protein family.

Authors:  Ulrike C Müller; Thomas Deller; Martin Korte
Journal:  Nat Rev Neurosci       Date:  2017-03-31       Impact factor: 34.870

8.  A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.

Authors:  Tyler J Perlenfein; Regina M Murphy
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

9.  Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.

Authors:  Viviana Soto-Mercado; Miguel Mendivil-Perez; Carlos Velez-Pardo; Francisco Lopera; Marlene Jimenez-Del-Rio
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 10.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.